Seeking men and women with mild to moderate COVID-19 for a study of an investigational drug that contains monoclonal antibodies.
We are studying whether an investigational drug containing one or more monoclonal antibodies is more effective than treatment with a placebo (looks like the investigational drug but contains no medicine) for mild to moderate COVID-19. Participants have a one in five chance of receiving the placebo or a single investigational drug. The rest will receive a combination of investigational drugs. All participants will also receive the standard treatment for COVID-19.
What we're hoping for
We hope to evaluate whether the investigational drug containing monoclonal antibodies is safe and effective in treating mild to moderate COVID-19 illness.
ClinicalTrials.gov Identifier: NCT04634409